D-0009-2015 Class II Terminated
FDA drug recall D-0009-2015 was initiated by Mylan Pharmaceuticals Inc. on Jul 3, 2014 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules: A pharmacist reported a rogue tablet of different size and markings in bottle of Metoprolol The recall status is terminated (terminated Sep 20, 2016). Affected quantity: 15,966 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 15, 2014
- Initiation Date
- Jul 3, 2014
- Termination Date
- Sep 20, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 15,966 bottles
Product description
Metoprolol Succinate Extended-release Tablets, USP 50mg, 90-count Bottles, Rx only, Mfg by Mylan Pharmaceuticals, Inc. Morgantown, WV 26505. NDC 0378-4596-77.
Reason for recall
Presence of Foreign Tablets/Capsules: A pharmacist reported a rogue tablet of different size and markings in bottle of Metoprolol
Distribution pattern
Nationwide
Code information
Lot 3023805 Exp. 11/15
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0009-2015
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026